DK1729796T3 - Behandling af tryksår - Google Patents

Behandling af tryksår

Info

Publication number
DK1729796T3
DK1729796T3 DK05731043T DK05731043T DK1729796T3 DK 1729796 T3 DK1729796 T3 DK 1729796T3 DK 05731043 T DK05731043 T DK 05731043T DK 05731043 T DK05731043 T DK 05731043T DK 1729796 T3 DK1729796 T3 DK 1729796T3
Authority
DK
Denmark
Prior art keywords
treatment
pressure ulcers
pressure
pressure sore
sore
Prior art date
Application number
DK05731043T
Other languages
Danish (da)
English (en)
Inventor
Eric R First
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1729796T3 publication Critical patent/DK1729796T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Processing Of Meat And Fish (AREA)
DK05731043T 2004-03-31 2005-03-28 Behandling af tryksår DK1729796T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/814,764 US20050220821A1 (en) 2004-03-31 2004-03-31 Pressure sore treatment
PCT/US2005/010461 WO2005097178A1 (en) 2004-03-31 2005-03-28 Pressure sore treatment

Publications (1)

Publication Number Publication Date
DK1729796T3 true DK1729796T3 (da) 2009-01-19

Family

ID=34964467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05731043T DK1729796T3 (da) 2004-03-31 2005-03-28 Behandling af tryksår

Country Status (10)

Country Link
US (2) US20050220821A1 (de)
EP (1) EP1729796B1 (de)
JP (2) JP2007531747A (de)
AT (1) ATE412424T1 (de)
AU (1) AU2005231360B2 (de)
BR (1) BRPI0509478A (de)
CA (1) CA2561588C (de)
DE (1) DE602005010676D1 (de)
DK (1) DK1729796T3 (de)
WO (1) WO2005097178A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073208A1 (en) * 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
FR2879462B1 (fr) * 2004-12-21 2008-12-26 Sod Conseils Rech Applic Utilisation de toxine botulique pour une insensibilisation locale prolongee
US20070238630A1 (en) * 2006-03-29 2007-10-11 Phillips Douglas H Subcutaneous skin cleanser
EP3103472A1 (de) * 2012-03-22 2016-12-14 ReVance Therapeutics, Inc. Verfahren zur behandlung von falten mit chemodenervierenden topischen wirkstoffen

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330527A (en) * 1979-11-13 1982-05-18 Teruo Arima Wound treatment agent
US4805605A (en) * 1988-01-11 1989-02-21 Glassman Medical Products, Inc. Abduction pillow
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5562907A (en) * 1993-05-14 1996-10-08 Arnon; Stephen S. Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
JPH07118165A (ja) * 1993-10-22 1995-05-09 Asahi Chem Ind Co Ltd カルシトニン遺伝子関連ペプチド類を含有する経皮吸収組成物
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) * 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
DE69526340T2 (de) * 1994-05-09 2002-11-14 William J Binder Botulinumtoxin ZUR REDUKTION VON Migraine -KOPFSCHMERZEN
US5670484A (en) * 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
JPH0840926A (ja) * 1994-08-03 1996-02-13 Yakurigaku Chuo Kenkyusho:Kk 皮膚潰瘍治療薬
GB9508204D0 (en) * 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
ATE239491T1 (de) * 1995-06-06 2003-05-15 L Bruce Pearce Verbesserte zusammensetzungen und verfahren zur chemodenervation mit neurotoxinen
US5851522A (en) * 1995-06-07 1998-12-22 Trustees Of Tufts College Enhancing keratinocyte migration
US6670337B1 (en) * 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
BRPI9908182C1 (pt) * 1998-02-27 2021-05-25 Biora Ab composições de proteína de matriz para cura de feridas
US6524568B2 (en) * 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
MXPA01004254A (es) * 1998-10-27 2002-04-24 Mayo Foundation Metodos para intensificar la curacion de heridas.
US6139845A (en) * 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6429189B1 (en) * 1999-12-10 2002-08-06 Botulinum Toxin Research Associates, Inc. Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
US6143306A (en) * 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6464986B1 (en) * 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) * 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
WO2002012479A2 (en) * 2000-08-07 2002-02-14 Zymogenetics, Inc. Zcys9: a member of the cystatin superfamily
JP4096115B2 (ja) * 2000-08-10 2008-06-04 輝夫 西田 皮膚創傷治癒促進剤
US6678651B2 (en) * 2000-09-15 2004-01-13 Mindspeed Technologies, Inc. Short-term enhancement in CELP speech coding
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
CA2431308C (en) * 2000-12-07 2010-04-13 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) * 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US20020192239A1 (en) * 2001-01-09 2002-12-19 Borodic Gary E. Use of botulinum toxin for the treatment of chronic facial pain
US7108683B2 (en) * 2001-04-30 2006-09-19 Kci Licensing, Inc Wound therapy and tissue management system and method with fluid differentiation
CN1258381C (zh) 2001-07-27 2006-06-07 路易斯安那州州立大学及农业机械学院管理委员会 用在痤疮治疗或预防中的肉毒杆菌毒素
WO2003015808A1 (en) * 2001-08-16 2003-02-27 Hnat Thomas M Method and composition for treatment of wounds and burns
AU2003212473A1 (en) * 2002-03-01 2003-09-16 Solstice Neurosciences, Inc. Methods of treating nerve entrapment syndromes
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
ATE423553T1 (de) * 2002-08-12 2009-03-15 Actavis Group Hf Verwendung von cgrp-antagonisten-verbindungen zur behandlung von psoriasis
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
KR20050052666A (ko) * 2002-10-10 2005-06-03 다이버사 코포레이션 프로테아제, 이를 암호화하는 핵산, 및 이를 제조하고사용하는 방법
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
CA2557814A1 (en) * 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
ES2691498T3 (es) * 2004-03-03 2018-11-27 Revance Therapeutics, Inc. Aplicación tópica y liberación transdérmica de toxinas botulínicas
EP1824488B1 (de) * 2004-05-07 2017-08-09 Algenis SpA Phycotoxine und verwendungen damit
US7179474B2 (en) * 2004-09-03 2007-02-20 Allergan, Inc. Methods for treating a buttock deformity
US20060058238A1 (en) * 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
WO2006035225A1 (en) * 2004-09-27 2006-04-06 Merz Pharma Gmbh & Co. Kgaa Clostridial neurotoxins for use in tissue healing
MX2008010258A (es) * 2006-02-09 2008-10-01 Aderans Res Inst Inc Aparato y metodos para suministrar fluido y material a un sujeto.
US9283217B2 (en) * 2011-11-10 2016-03-15 Allergan, Inc. Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

Also Published As

Publication number Publication date
EP1729796A1 (de) 2006-12-13
AU2005231360B2 (en) 2009-10-29
EP1729796B1 (de) 2008-10-29
JP2013075902A (ja) 2013-04-25
CA2561588C (en) 2012-08-28
US8865177B2 (en) 2014-10-21
WO2005097178A1 (en) 2005-10-20
ATE412424T1 (de) 2008-11-15
AU2005231360A1 (en) 2005-10-20
BRPI0509478A (pt) 2007-09-11
DE602005010676D1 (de) 2008-12-11
US20080050404A1 (en) 2008-02-28
US20050220821A1 (en) 2005-10-06
JP5674164B2 (ja) 2015-02-25
CA2561588A1 (en) 2005-10-20
JP2007531747A (ja) 2007-11-08

Similar Documents

Publication Publication Date Title
ATE462443T1 (de) Dehnungsstreifenbehandlung mit botulinumtoxin
DK2154151T3 (da) Clostridiumtoksinaktiverbare clostridiumtoksiner
ATE424159T1 (de) Katheter
TW200503751A (en) Methods for treating sinus headache
BR0307496A (pt) Uso de uma neurotoxina clostridiana, bem como composição farmacêutica utilizável no tratamento de um distúrbio da glândula mamária
DK1322324T3 (da) Fremgangsmåder til behandling af muskelskader
DK2282766T3 (da) Suturlinie-indgivelsesteknik med anvendelse af botulinumtoksiner
NO20080622L (no) Disykloalkylurea-glukokinase aktivatorer
ATE416191T1 (de) Abbaubare clostridientoxine
DK1558279T3 (da) Botulinumtoksin til behandling af ulcus pepticum og gastroesophageal reflux-sygdom
AR065033A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
DE60111570D1 (de) Isoindolin-1-on als glukokinaseaktivatoren
NO20070391L (no) Jernsulfatbasert fosfatadsorbent
WO2008051197A3 (en) Small-molecule botulinum toxin inhibitors
ATE347898T1 (de) Botulinustoxine zur behandlung von priapismus
RS54863B1 (sr) Upotreba sredstva za suzbijanje vlažne truleži i postupak suzbijanja iste
WO2010014854A3 (en) Antibodies that neutralize botulinum neurotoxins
ATE469976T1 (de) Mikrobielle vitamin-c-produktion
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
CY1114792T1 (el) Κλωστριδιακες τοξινες για χρηση στην θεραπεια προωρης εκσπερματισης
ATE444076T1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
DK1729796T3 (da) Behandling af tryksår
WO2009130600A8 (en) Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
BRPI0514836A (pt) uso de toxina botulìnica para tratamento de uma deformidade da nádega
ATE529108T1 (de) Zellmigrationsmodulierende verbindungen